http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6acbb3838b3ef257f997a7de19367b06
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Spicer |
| name | James Spicer |
| given-name | James |
| organization-name | School of Cancer and Pharmaceutical Sciences, King’s College London, Guy’s Hospital, London, UK School of Cancer and Pharmaceutical Sciences, King's College London, London, UK; Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, UK Division of Cancer Studies, King's College London, Guy’s Hospital, London, England School of Cancer and Pharmaceutical Sciences, King’s College London , London , United Kingdom Department of Medical Oncology, Guy's & St Thomas’ NHS Trust, London, UK; Division of Cancer Studies, King's College London, London, UK King's College London; and Guy's & St Thomas' National Health Service Foundation Trust, London, United Kingdom Imperial Cancer Research Fund Clinical Oncology Unit, Guys Hospital, London, UK Authors' Affiliations: 1Drug Development Unit, Royal Marsden NHS Foundation Trust; 2Division of Clinical Studies; 3Cancer Research UK and Engineering and Physical Sciences Research Council Cancer Imaging Centre, The Institute of Cancer Research, Sutton; 4East Surrey Hospital, Redhill, Surrey, United Kingdom; 5University of Colorado, Denver, Colorado; 6Dana-Farber Cancer Institute, Boston, Massachusetts; and 7OSI Pharmaceuticals LLC, Northbrook, Illinois 3King's College London, Guy's Hospital, London, United Kingdom. Guy's Hospital, Department of Medical Oncology, 3rd Floor, Thomas Guy House, St Thomas Street, London, SE1 9RT, UK. James.Spicer@gstt.nhs.uk Division of Cancer Studies, Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, London, UK Authors' Affiliation: Guy's Hospital, London, United Kingdom 5King's College London, Guy's Hospital, London, United Kingdom. From the Drug Development Unit, the Royal Marsden National Health Service Foundation Trust, and The Institute of Cancer Research, Sutton, Surrey; Northern Institute for Cancer Research, Newcastle upon Tyne; Boehringer Ingelheim, Bracknell; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; and Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany. Emma Beddowes, Javier Garcia Corbacho, and Simon Pacey, University of Cambridge, Cambridge; James Spicer, Dimitra Repana, Teresa Szyszko, and Gary Cook, King's College London; Pui Ying Chan, Jeremy P. Steele, Peter Schmid, Michael Sheaff, and Peter W. Szlosarek, St Bartholomew’s Hospital; Ramsay Khadeir, Peter Schmid, and Peter W. Szlosarek, Queen Mary University of London, London, United Kindgom; and Monica Diaz, Xiaoxing Feng, Amanda Johnston, Jim Thomson, Bor-Wen Wu, and John Bomalaski, Polaris... Guy's Hospital, Department of Medical Oncology, 3rd Floor, New Guy's House, St Thomas Street, London SE1 7EH, UK. James.Spicer@gstt.nhs.uk Authors' Affiliations: 1Oncology, Postgraduate Medical School, University of Surrey, Guildford, United Kingdom; 2Guys and St. Thomas's Hospital; 3Targeted Therapy Laboratory, Chester Beatty Laboratories, London, United Kingdom; 4Churchill Hospital, The Churchill, Oxford, United Kingdom; 5Mayo Clinic, Minneapolis, Minnesota; 6Targeted and Biological Therapies Group, Leeds Institute of Molecular Medicine Group, Leeds, United Kingdom; 7Oncolytics Biotech, Inc., Calgary, Alberta, Canada; and 8Ohio State University Medical Center, Columbus, Ohio Siow Ming Lee, Mary Falzon, Martin Forster, Arrigo Capitanio, Robin Rudd, Natasha Iles, Yenting Ngai, Michael Gandy, Rachel Lillywhite, and Allan Hackshaw, University College London, University College London Hospitals; James Spicer, Guy’s and St Thomas’s NHS Foundation Trust; Conrad Lewanski, Charing Cross Hospital, London; Fiona Blackhall, The Christie NHS Foundation Trust, Manchester; Marianne Nicolson, Aberdeen Royal Infirmary, Aberdeen; Abhro Chaudhuri, Lincoln County Hospital, Lincoln; Gary... Authors' Affiliations: 1The Royal Marsden Hospital NHS Foundation Trust, 2The Institute of Cancer Research, Sutton, Surrey, United Kingdom, 3The Churchill Hospital, Headington, Oxford, United Kingdom, and 4Chroma Therapeutics Ltd., Abingdon, Oxon, United Kingdom School of Cancer & Pharmaceutical Sciences, King’s College London, Guy’s Hospital, London, UK King's Health Partners at Guy's Hospital, London, UK. james.spicer@kcl.ac.uk. King's College London, Guy's Hospital, London, UK. |
Incoming Links
Total number of triples: 127.